These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34454584)

  • 1. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
    Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
    Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating liquid biopsies for methylomic profiling of prostate cancer.
    Silva R; Moran B; Russell NM; Fahey C; Vlajnic T; Manecksha RP; Finn SP; Brennan DJ; Gallagher WM; Perry AS
    Epigenetics; 2020; 15(6-7):715-727. PubMed ID: 32000564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential.
    Bjerre MT; Nørgaard M; Larsen OH; Jensen SØ; Strand SH; Østergren P; Fode M; Fredsøe J; Ulhøi BP; Mortensen MM; Jensen JB; Borre M; Sørensen KD
    Cells; 2020 May; 9(6):. PubMed ID: 32486483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genes.
    Berglund A; Yamoah K; Eschrich SA; Falahat R; Mulé JJ; Kim S; Matta J; Dutil J; Ruiz-Deya G; Ortiz Sanchez C; Wang L; Park H; Banerjee HN; Lotan T; Barry KH; Putney RM; Kim SJ; Gwede C; Kresovich JK; Kim Y; Lin HY; Dhillon J; Chakrabarti R; Park JY
    Cancer Med; 2024 Aug; 13(16):e70044. PubMed ID: 39162297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Barault L; Amatu A; Siravegna G; Ponzetti A; Moran S; Cassingena A; Mussolin B; Falcomatà C; Binder AM; Cristiano C; Oddo D; Guarrera S; Cancelliere C; Bustreo S; Bencardino K; Maden S; Vanzati A; Zavattari P; Matullo G; Truini M; Grady WM; Racca P; Michels KB; Siena S; Esteller M; Bardelli A; Sartore-Bianchi A; Di Nicolantonio F
    Gut; 2018 Nov; 67(11):1995-2005. PubMed ID: 28982739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
    Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
    Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
    Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
    Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct methylome profile of cfDNA in AMI patients reveals significant alteration in cAMP signaling pathway genes regulating cardiac muscle contraction.
    Dash M; Mahajan B; Shah S; Dar GM; Sahu P; Sharma AK; Nimisha ; Saluja SS
    Clin Epigenetics; 2024 Oct; 16(1):144. PubMed ID: 39415189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.
    Charlton PV; O'Reilly D; Philippou Y; Rao SR; Lamb ADG; Mills IG; Higgins GS; Hamdy FC; Verrill C; Buffa FM; Bryant RJ
    Prostate; 2024 Jul; 84(10):977-990. PubMed ID: 38654435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.
    Zhao S; Geybels MS; Leonardson A; Rubicz R; Kolb S; Yan Q; Klotzle B; Bibikova M; Hurtado-Coll A; Troyer D; Lance R; Lin DW; Wright JL; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Clin Cancer Res; 2017 Jan; 23(1):311-319. PubMed ID: 27358489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.
    Kim JW; Kim ST; Turner AR; Young T; Smith S; Liu W; Lindberg J; Egevad L; Gronberg H; Isaacs WB; Xu J
    PLoS One; 2012; 7(10):e48455. PubMed ID: 23119026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome.
    Li S; Li W; Liu B; Krysan K; Dubinett SM
    Cancer Res Commun; 2024 Jul; 4(7):1738-1747. PubMed ID: 38856716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signatures of Prostate Cancer in peripheral T-cells.
    Mehdi A; Cheishvili D; Arakelian A; Bismar TA; Szyf M; Rabbani SA
    BMC Cancer; 2020 Jun; 20(1):588. PubMed ID: 32576165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.